Predict your next investment

Cureab company logo
HEALTHCARE | Drug Development
cureab.ch

See what CB Insights has to offer

Founded Year

2012

Stage

Incubator/Accelerator | Alive

Total Raised

$10K

Last Raised

$10K | 2 yrs ago

About Cureab

Cureab develops antibodies for cancer therapy focussing on lung, liver and colorectal cancer.

Cureab Headquarter Location

Zurich,

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cureab

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cureab is included in 1 Expert Collection, including Cancer.

C

Cancer

3,592 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Cureab Patents

Cureab has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Hepatology
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/21/2017

Clusters of differentiation, Hepatology, Immunology, Transcription factors, Immune system

Application

Application Date

11/21/2017

Grant Date

Title

Related Topics

Clusters of differentiation, Hepatology, Immunology, Transcription factors, Immune system

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.